The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of …
View Press-Release
The global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high in spite of significant improvements in sanitation practices …
View Press-Release
Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, …
View Press-Release
According to the new market research report by MarketsandMarkets, infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 …
View Press-Release
Growth in infectious disease diagnostics instruments market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to …
View Press-Release
Growth in infectious disease diagnostics market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, …
View Press-Release
Growth in infectious disease diagnostics market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized …
View Press-Release